Efficacy and safety of acupuncture in Chronic MIGraine - a multicentre, randomised, controlled clinical trial

Ruhr-University Bochum (Germany)0 个研究点目标入组 1,295 人开始时间: 2005年8月2日最近更新: 2017年10月30日

适应症

试验速览

暂无简介。

•1. Member of participating health insurance company
•2. Age between 18 and 65
•3. Signed informed consent
•4. Ability to read and speak sufficient German
•5. First migraine attack before the age of 50
•6. First migraine diagnosis at least six months before
•7. Two to six migraine attacks in four weeks
•8. Duration of migraine attacks 4 to 72 hours without acute-medication or at least 2 hours with acute-medication
•9. Two migraine characteristics have to be met, at least one accompaniment

•1. Severe migraine-attacks with inability to go to work on more than four days a month
•2. Other neurological disease
•3. Seconday headache
•4. Neuralgia of the face or head
•5. More than six days of non-migrainous headache a month
•6. Experience with acupuncture against migraine
•7. Any acupuncture in the last 12 months
•8. Previous unsuccessful therapy with beta-blocker
•9. Drug abuse
•10. Pregnancy
•11. Nursing mother
•12. Insufficient contraception
•13. Intake of antipsychotic or antidepressant drugs
•14. Participation in another clinical trial
•15. Intake of analgesics on more than three days a month because of other chronic pain
•16. Use of prophylactic migraine medication in the last six months
•17. Ongoing cortisone therapy
•18. Epilepsy
•19. Manifest psychiatric disease

发起方

Ruhr-University Bochum (Germany)